compare retatrutide and tirzepatide vs vs Semaglutide Retatrutide vs. Tirzepatide — Key

My A1C dropped from 6.1 to 5.4

The studies demonstrated substantial weight reduction, along with significant improvements in several obesity-associated comorbidities, including knee osteoarthritis pain, moderate-to-severe obstructive sleep apnea (OSA), and type 2 diabetes

A medicine can reduce weight in a trial and still require more evidence about long-term safety, cardiovascular outcomes, gallbladder issues, muscle preservation, and durability after stopping treatment

The upfront costs of GLP-1s are an ongoing concern for both public and private payers, and some employers and state Medicaid programs are now restricting coverage, despite recognizing their effectiveness at treating obesity